Compare GSK plc (GSK) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Jones Lang LaSalle Inc — how do they compare? GSK plc trades at $50.58 (market cap $102.60B), while Jones Lang LaSalle Inc trades at $364.99 (market cap $16.72B). The key difference: GSK plc is far larger — about 6.1× Jones Lang LaSalle Inc's market cap, and GSK plc pays a 3.57% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| GSK | JLL | |
|---|---|---|
Market Cap | $102.60B | $16.72B |
Sector | Health | Real Estate |
52-Week High | $61.18 | $373.24 |
52-Week Low | $38.22 | $280.16 |
Enterprise Value | $123.04B | $19.48B |
Dividend Yield | 3.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
